Lancet— 510(k) K262211

Substantially Equivalent

Tianjin Huahong Technology Co., Ltd.

FDA 510(k) clearance K262211 for Lancet, Substantially Equivalent on 2026-07-22. Applicant: Tianjin Huahong Technology Co., Ltd.. Device class: 2.

Summary

Tianjin Huahong Technology's Lancet is filed under QRL, multiple use blood lancets for single patient use only. The name is generic, and the record gives no model numbers or specs.

Class II, 21 CFR 878.4850. General and Plastic Surgery is both the classification panel and the review panel. It came in as a Special 510(k).

Tianjin Huahong filed from Tianjin, China. The decision came 22 calendar days after FDA received it (June 30 to July 22, 2026).

Clearance details

Applicant
Tianjin Huahong Technology Co., Ltd.
Product code
Product code QRL
Device class
Class 2
Regulation
21 CFR 878.4850
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Tianjin, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code QRL

view all

More clearances from Tianjin Huahong Technology Co., Ltd.

view all

Adverse events under product code QRL

product code QRL
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.